The laboratory animal diets market in North America is expected to grow from US$ 1,719.20 million in 2022 to US$ 2,304.19 million by 2028; it is estimated to grow at a CAGR of 5.0% from 2022 to 2028.

Rising Use of Mice Models in Virology and Infectious Disease Studies Boost North America Laboratory Animal Diets Market Growth

Mice models are essential tools for studying the pathogenesis of infectious diseases and for the preclinical evaluation of vaccines and therapies against various human pathogens. The use of genetically defined inbred mouse strains, humanized mice, and gene knockout mice has enabled the research community to study pathogens that cause diseases and explain the role of specific host genes in controlling or promoting diseases. It also helps determine potential targets for the prevention or identification of treatments for various infectious agents. With the growing incidences of new infectious diseases, the animal model has become a vital tool for studying disease mechanisms and developing therapeutics. Mice with xenografted human immune systems have been used to study the pathogenesis of various infectious agents, including Plasmodium falciparum (malaria), Mycobacterium tuberculosis , dengue virus, and influenza virus. These models have been beneficial in studying HIV, which includes analyzing viral and host factors that promote viral replication and HIV interactions with the host’s immune response. They are also helpful as platforms for testing therapeutic approaches to control HIV infection. Mouse models are widely used for preclinical screening of vaccines/therapies because of their reproducibility, low cost, and ease of experimental manipulation. Over the past century, advancements in vaccines, antibiotics/antivirals, and infection control measures have significantly reduced the burden of infectious diseases across the region. However, there has been an increase in contagious viral diseases. Mouse models are considered the best small animal models to be tested for hepatitis B virus (HBV), hepatitis C virus (HCV), Zika virus, SARS-CoV-2, and cytomegalovirus (CMV). According to the WHO, more than 17 million people die from infectious diseases yearly. Over the past two decades, over 30 new infectious diseases have emerged. According to UNAIDS, 38 million people were affected by HIV by the end of 2019. Mouse models have been widely used for various viral studies due to their small size, low cost, ease of use, and high reproducibility. To study the effect of the vaccines and therapies, these mice models are given a particular standardized diet. The prevalence of viral and infectious diseases is driving the demand for mice models; hence, the requirement for a specific diet for mice models has increased. This is driving the growth of the laboratory animal diet market in North America.

Market Overview

The North America laboratory animal diets market is segmented into the US, Canada, and Mexico. North America accounted for the largest share of the global market in 2021, owing to the increasing demand for laboratory animals by a large number of research institutions and well-established players in the industry across developed countries. Additionally, the rising need for animal models is due to the increased use of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technique. In addition, the development and introduction of personalized medicine products and services mainly emerged in the US market. Concerns regarding the adverse effects of certain drugs and the desire to increase patient participation in medical decisions have the potential to boost the acceptance of personalized medicine in the US. Moreover, the Precision Medicine Initiative was introduced by the government in the US. Under this initiative, the government intends to increase knowledge related to cancer genetics and biology, discover more effective therapeutics for chronic disorders, and promote the use of precision medicine. Rapid developments in regenerative medicine and tissue engineering have witnessed an increasing inclination toward the clinical translation of breakthrough technologies. Various domesticated and companion animals are used in personalized medicine, regenerative medicine, and tissue engineering studies.

North America Laboratory Animal Diets Market Revenue and Forecast to 2028 (US$ Million)

North America Laboratory Animal Diets Market Segmentation

The North America laboratory animal diets market is segmented on the basis of diet type, animal, application, end user, and country.

Based on diet type, the North America laboratory animal diets market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment is likely to register the largest share of the market in 2022.

Based on animal, the North America laboratory animal diets market is segmented into mouse, cat, dog, rabbit, chicken, and others. The mouse segment is likely to register the largest share of the market in 2022.

Based on application, the North America laboratory animal diets market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment is likely to register the largest share of the market in 2022.

Based on end user, the North America laboratory animal diets market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment is likely to register the largest share of the market in 2022.

Based on country, the North America laboratory animal diets market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.

Altromin Spezialfutter GmbH & Co. KG; Bio-Serv; Dyets, Inc.; Envigo; LabDiet; Research Diets Inc.; SAFE; Special Diet Services; and Specialty Feeds are the leading companies operating in the laboratory animal diets market in North America.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Laboratory Animal Diet Market – By Diet Type
1.3.2 North America Laboratory Animal Diet Market – By Animal
1.3.3 North America Laboratory Animal Diet Market – By Application
1.3.4 North America Laboratory Animal Diet Market – By End User
1.3.5 North America Laboratory Animal Diet Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Laboratory Animal Diet Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Laboratory Animal Diet Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Consumption of Personalized Medicines
5.1.2 Rising Usage of Mice Models in Virology and Infectious Disease
5.2 Market Restraints
5.2.1 High Cost of Laboratory Animal Diet due to Maintenance and Wastage
5.3 Market Opportunities
5.3.1 Rising Demand for Humanized Mice Models
5.4 Future Trends
5.4.1 Growing Inclination Toward Customized Diet Plan for Laboratory Animals
5.5 Impact Analysis
6. Laboratory Animal Diet Market – North America Analysis
6.1 North America Laboratory Animal Diet Market Revenue Forecast & Analysis
7. North America Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Diet Type
7.1 Overview
7.2 North America Laboratory Animal Diet Market, By Diet Type 2021 & 2028 (%)
7.3 Standard Diet
7.3.1 Overview
7.3.2 Standard Diet Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Irradiated Diet
7.4.1 Overview
7.4.2 Irradiated Diet Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Autoclavable Diet
7.5.1 Overview
7.5.2 Autoclavable Diet Market Revenue and Forecast to 2028 (US$ Mn)
8. North America Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Animal
8.1 Overview
8.2 North America Laboratory Animal Diet Market, By Animal 2021 & 2028 (%)
8.3 Mouse
8.3.1 Overview
8.3.2 Mouse Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Cat
8.4.1 Overview
8.4.2 Cat Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Dog
8.5.1 Overview
8.5.2 Dog Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Rabbit
8.6.1 Overview
8.6.2 Rabbit Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Chicken
8.7.1 Overview
8.7.2 Chicken Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Application
9.1 Overview
9.2 North America Laboratory Animal Diet Market, By Application 2021 & 2028 (%)
9.3 Drug Discovery and Personalized Medicine
9.3.1 Overview
9.3.2 Drug Discovery and Personalized Medicine Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Regenerative Medicines
9.4.1 Overview
9.4.2 Regenerative Medicines Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Pathology of Infectious Diseases
9.5.1 Overview
9.5.2 Pathology of Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
9.6 Drug Toxicity and Efficacy Testing
9.6.1 Overview
9.6.2 Drug Toxicity and Efficacy Testing Market Revenue and Forecast to 2028 (US$ Mn)
9.7 Others
9.7.1 Overview
9.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By End User
10.1 Overview
10.2 North America Laboratory Animal Diet Market, By End User 2021 & 2028 (%)
10.3 Pharmaceutical & Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Pharmaceutical & Biopharmaceutical Companies Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Research & Academic Institutes
10.4.1 Overview
10.4.2 Research & Academic Institutes Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. North America Laboratory Animal Diet Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Overview
11.1.1 North America: Laboratory Animal Diet Market, by Country, 2021 & 2028 (%)
11.1.1.1 US: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 US: Laboratory Animal Diet Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 US: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 US: Laboratory Animal Diet Market, by Animal– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 US: Laboratory Animal Diet Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.6 US: Laboratory Animal Diet Market, by End user– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 Canada: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Canada: Laboratory Animal Diet Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Canada: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 Canada: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 Canada: Laboratory Animal Diet Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.6 Canada: Laboratory Animal Diet Market, by End user– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 Mexico: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 Mexico: Laboratory Animal Diet Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 Mexico: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 Mexico: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 Mexico: Laboratory Animal Diet Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.6 Mexico: Laboratory Animal Diet Market, by End user– Revenue and Forecast to 2028 (US$ Million)
12. North America Laboratory Animal Diet Market– Industry Landscape
12.1 Overview
13. Company Profiles
13.1 Envigo
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Altromin Spezialfutter GmbH & Co. KG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 LabDiet
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 SAFE
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Dyets, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Special Diet Services
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Specialty Feeds
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Research Diets Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio-Serv
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. US: Laboratory Animal Diet Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Laboratory Animal Diet Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Laboratory Animal Diet Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 14. Merger and Acquisition Development Done By Company
Table 15. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Laboratory Animal Diet Market Segmentation
Figure 2. North America Laboratory Animal Diet Market, By Country
Figure 3. North America Laboratory Animal Diet Market Overview
Figure 4. North America Laboratory Animal Diet Market, By Diet Type
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Laboratory Animal Diet Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Laboratory Animal Diet Market, by Diet Type 2021 & 2028 (%)
Figure 10. North America Standard Diet Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. North America Irradiated Diet Market Revenue and Forecasts To 2028 (US$ MN)
Figure 12. North America Autoclavable Diet Market Revenue and Forecasts To 2028 (US$ MN)
Figure 13. North America Laboratory Animal Diet Market, by Animal 2021 & 2028 (%)
Figure 14. North America Mouse Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Cat Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. North America Dog Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. North America Rabbit Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. North America Chicken Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. North America Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Laboratory Animal Diet Market, by Application 2021 & 2028 (%)
Figure 21. North America Drug Discovery and Personalized Medicine Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. North America Regenerative Medicines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Pathology of Infectious Diseases Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. North America Drug Toxicity and Efficacy Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. North America Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. North America Laboratory Animal Diet Market, by End User 2021 & 2028 (%)
Figure 27. North America Pharmaceutical & Biopharmaceutical Companies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. North America Research & Academic Institutes Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. North America Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. North America: Laboratory Animal Diet Market Revenue Overview, By Key Country – Revenue (2021) (US$ Million)
Figure 31. North America: Laboratory Animal Diet Market, By Country, 2021 & 2028 (%)
Figure 32. US: Laboratory Animal Diet Market Revenue and Forecast To 2028 (US$ Million)
Figure 33. Canada: Laboratory Animal Diet Market Revenue and Forecast To 2028 (US$ Million)
Figure 34. Mexico: Laboratory Animal Diet Market Revenue and Forecast To 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America laboratory animal diet market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the North America laboratory animal diet market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the laboratory animal diet market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

● Altromin Spezialfutter GmbH & Co. KG
● Bio-Serv
● Dyets, Inc.
● Envigo
● LabDiet
● Research Diets Inc.
● SAFE
● Special Diet Services
● Specialty Feeds

At 5.0% CAGR, the North America Laboratory Animal Diet Market is speculated to be worth US$ 2,304.19 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the North America laboratory animal diet market was valued at US$ 1,719.20 million in 2022 and is expected to reach US$ 2,304.19 million by 2028, registering a CAGR of 5.0% from 2022 to 2028. Growing consumption of personalized medicines and rising usage of mice models in virology and infectious diseases are the critical factors attributed to the market expansion.

Medicine is moving away from the “one size fits all” paradigm. The vision of personalized medicine for the 21st century is to provide the right patient with the right drug in the correct dose at the right time. The practical application of personalized medicine depends heavily on the availability of rigorous diagnostic tools that allow the optimal selection of therapeutic products to improve patient outcomes. According to the Food and Drug Administration (FDA), personalized medicine aims to increase benefits and reduce patient risks by targeting prevention and treatment more effectively. Personalized medicines are treatments based on the environment, the patient’s unique biological makeup, and lifestyle. Companies are focused on introducing new companion diagnostics for various types of cancer. Personalized medicines are concepts, practices, or modalities that expressly predict the human response to medicines and diseases based on intraspecific differences. Slight differences in genetic makeup can result in dramatic differences in response to drugs or disease. Researchers help in developing approaches to personalized medicines for many genetic disorders. These personalized medicines sometimes use custom genetic interventions, such as antisense-mediated exon skipping or genome editing, to restore protein function in a mutation-specific manner. In drug discovery and development, mice models have played an essential role by characterizing disease pathophysiology and associated injury mechanisms, identifying drug targets, and evaluating novel therapeutics for toxicity/safety, pharmacokinetics, pharmacodynamics, and efficacy. The specific model chosen for a particular drug to be tested and developed depends on the goal of the thorough study. The traditional use of animal models in drug discovery establishes and demonstrates non-clinical proof of concept for specific drug molecules’ safety, efficacy, and target of interest. Animal models can facilitate the development of personalized medicine approaches. Personalized medicine approaches need to be developed and preclinically tested in relevant cell and mouse models that ideally contain the human target sequences. The animal models used for personalized medicine research and drug discovery & development are provided with specific diets so that the animal model will react according to the human environment. Therefore, with the rising demand for personalized medicines, the Laboratory Animal Diet market is growing substantially.

On the contrary, high cost of laboratory animal diets due to maintenance and wastage hurdles the growth of North America laboratory animal diet market.

Based on diet type, the North America laboratory animal diet market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment held 60.1% market share in 2022, amassing US$ 1,032.77 million. It is projected to garner US$ 1,378.64 million by 2028 to expand at 4.9% CAGR during 2022–2028.

Based on animal, the North America laboratory animal diet market is segmented into mouse, cat, dog, rabbit, chicken, and others. The mouse segment held 42.3% market share in 2022, amassing US$ 727.57 million. It is projected to garner US$ 1,016.88 million by 2028 to expand at 5.7% CAGR during 2022–2028.

Based on application, the North America laboratory animal diet market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment held 49.4% market share in 2022, amassing US$ 849.04 million. It is projected to garner US$ 1,112.35 million by 2028 to expand at 4.6% CAGR during 2022–2028.

Based on end user, the North America end user market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment held 56.8% market share in 2022, amassing US$ 976.64 million. It is projected to garner US$ 1,297.66 million by 2028 to expand at 4.9% CAGR during 2022–2028.

Based on country, the North America laboratory animal diet market is segmented into the US, Canada, and Mexico. Our regional analysis states that the US captured 84.8% market share in 2022. It was assessed at US$ 1,457.36 million in 2022 and is likely to hit US$ 1,938.06 million by 2028, exhibiting a CAGR of 4.9% during the forecast period.

Key players dominating the North America laboratory animal diet market are Altromin Spezialfutter GmbH & Co. KG; Bio-Serv; Dyets, Inc.; Envigo; LabDiet; Research Diets Inc.; SAFE; Special Diet Services; and Specialty Feeds among others.